J Breast Cancer.
2017 Mar;20(1):117-117. 10.4048/jbc.2017.20.1.117.
Erratum: Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients
- Affiliations
-
- 1Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul, Korea.
- 2Department of Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea.
- 3Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jeongeon.lee@samsung.com
- KMID: 2379410
- DOI: http://doi.org/10.4048/jbc.2017.20.1.117
Abstract
- This article was published with a misspelled the date of acceptance. The date of acceptance should be corrected as "March 7, 2013".
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients
- Ipsilateral Breast Tumor Recurrence with Metachronous Contralateral Axillary Lymph Node Metastasis after Breast-Conserving Surgery with Axillary Lymph Node Dissection
- External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
- Surgical Options for Ipsilateral Breast Tumor Recurrence: Mastectomy Versus Repeat Breast-Conserving Surgery
- Recurrent and Second Breast Cancer Detected on Follow-Up Mammography and Breast Ultrasound after Breast-Conserving Surgery: Imaging Findings and Clinicopathologic Factors
